Powered by

Cronos Announces Re-Filing of Management's Discussion and Analysis for the Period Ended September 30, 2016

Mar 02, 2017 - Marketwired

Cronos Group Inc. (formerly PharmaCan Capital Corp.) (TSX VENTURE:MJN) ("Cronos Group" or the "Company") announces that it has re-filed Management's Discussion and Analysis of financial results for the three and nine months ended September 30, 2016 (the "MD&A") pursuant to a review by staff of the Ontario Securities Commission.

The MD&A has been re-filed to include with respect to the Company:

-- an analysis of year-to-date results including a comparison of financial